Thimerosal (ethylmercurithiosalicylate) is an organic mercury compound that has been used as a preservative in vaccines, intramuscular immune globulin preparations, skin test antigens, antivenoms, ophthalmic and nasal products, and tattoo inks [1–3]. It has 49.6% mercury by weight, and following its administration, its metabolite, ethylmercury, dissociates from thiosalicylic acid and binds to blood or other tissue. The extensive use of vaccines in today’s society has led to concerns about immunization safety. Today, children receive more total number of vaccinations given together during the first two years of life, leading to exposure to quantities of mercury that exceeds the safety guidelines through Thimerosal in vaccines.

The effect of mercury on the immune system has been studied mostly in rodents. These studies have revealed that subtoxic doses of mercury exposure in genetically susceptible H-2 mice strains result in the development of systemic autoimmunity

The sensitizing effects of Thimerosal in man are well documented.

It is more important and serious that mercury exposure can accelerate or aggravate spontaneously occurring, systemic autoimmune conditions.

However, Thimerosal, in a concentration-dependent manner, suppressed the secretion of proinflammatory cytokines

The U.S. Environmental Protection Agency (EPA) Safety of Exposure Standard is 0.1 g/kg body weight/day, equating to 7 g for a 70-kg adult. Fully vaccinated children receive as much as 237.5 g mercury from vaccines in doses of up to 25 g each, which far exceeds the EPA safety standard. Administration of the three thimerosal-containing influenza vaccines could raise this exposure to as high as 275 g mercury [3, 6]. Similarly, in areas with high seafood consumption, the levels of mercury in the blood can easily reach up to 20–30 g/L, which far exceeds the 5.8 g/L safety guideline set by the EPA. In our studies, we have used concentrations of 20 ng/ml or lower, which is readily achievable during childhood vaccinations, where an infant is exposed to 20–25 g/kg mercury during each vaccination.

In conclusion, the organic mercury compound thimerosal (EtHg) has initial immunosuppressive effects similar to those of MeHg. However, in contrast to MeHg, thimerosal treatment leads in genetically susceptible mice to a second phase with strong immunostimulation and autoimmunity, which is T-cell dependent, H-2 linked and may at least partly be due to the inorganic mercury derived from the metabolism of ethyl mercury.

Requests for package inserts for the ingredients of the experimental H1N1 vaccine were denied on the grounds that this was a study and that information is privileged.

However, we can still piece together some of the ingredients based upon the parental consent form. “MF59 is an adjuvant which is used in influenza vaccines licensed for the adults and/or elderly in many countries worldwide, but it is not contained in any vaccines currently approved in the United States.” (page 2)

Isn’t it interesting that the study states it is licensed for adults and elderly? This study is designed for children between the ages of 3 and 8 and they plan on shooting up newborns and pregnant women with this stuff? Buyer beware.

Here is what the World Association for Vaccine Education had to say about Squalene (MF59):

Squalene:C30H50 an Adjuvant

Too dangerous for human use, Squalene is not licensed for use in the United States.  Oil adjuvants like squalene have been ordinarily used to inflict diseases in animals – for experimentation and study. According to anthrax vaccine expert Gary Matsumoto and other reliable sources, the US military used an unlicensed, experimental anthrax vaccination laced with squalene, with disastrous consequences, including Gulf War Sydrome.

"On first blush, squalene seems like a good choice for an adjuvant. Manufactured naturally in the liver, squalene is a precursor for cholesterol. In addition, squalene can be purchased at health food stores in its more commonly known form, “shark liver oil.” However, ingested squalene has a completely different effect on the body than injected squalene. When molecules of squalene enter the body through an injection, even at concentrations as small as 10 to 20 parts per billion, it can lead to self-destructive immune responses, such as autoimmune arthritis and lupus.

Several mechanisms have been proposed to explain this reaction. Metabolically, squalene stimulates an immune response excessively and nonspecifically. More than two dozen peer-reviewed scientific papers from ten different laboratories throughout the U.S., Europe, Asia, and Australia have been published documenting the development of autoimmune disease in animals subjected to squalene-based adjuvants.

In our small cohort, the substantial majority (95%) of overtly ill deployed GWS patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene. In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene. Neither patients with idiopathic autoimmune disease nor healthy controls had detectable serum antibodies to squalene. The majority of symptomatic GWS patients had serum antibodies to squalene.

Originally posted by liveandlearn
I realized I left out a portion on squalene and didn't have enough characters left so here it is for those who may be interested.

Squalene
PubMed

In our small cohort, the substantial majority (95%) of overtly ill deployed GWS patients had antibodies to squalene. All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene. In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene. Neither patients with idiopathic autoimmune disease nor healthy controls had detectable serum antibodies to squalene. The majority of symptomatic GWS patients had serum antibodies to squalene.

I come from a family with numerous autoimmune disorders that has most recently affected my niece, who recently discovered her susceptibility and onset of the human papilloma virus, and my kids, one of which has asperger's syndrome and the other has no tolerance for viruses, from what I have seen. She is just as I was at that age, catching every cold and flu bug coming down the pike, including strep.